Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet

Nutrition

Volumn 30, Issue 11-12, 2014, Pages 1423-1432

  Núñez, Ivanna Novotny ^a   Galdeano, Carolina Maldonado ^a,b   de Moreno de LeBlanc, Alejandra ^a   Perdigón, Gabriela ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Fermented milk; Gut immunity; Gut microbiota; Humoral immune response; Obesity; Probiotic

Indexed keywords

IMMUNOGLOBULIN A; PROBIOTIC AGENT; BIOLOGICAL MARKER; FAT INTAKE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BLOOD ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FERMENTED MILK; FERMENTED PRODUCT; HISTOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS CASEI; LIPID DIET; LIVER; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PHAGOCYTOSIS; SMALL INTESTINE; WEIGHT REDUCTION; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; COMPLICATION; FAT INTAKE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE MUTANT; MUCOSAL IMMUNITY; PATHOLOGY;

ANIMALS; BACTEROIDES; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; DIET, HIGH-FAT; DIETARY FATS; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTOBACILLUS CASEI; LIVER; MACROPHAGES; MICE, INBRED BALB C; MICE, OBESE; MICROBIOTA; OBESITY; PHAGOCYTOSIS; PROBIOTICS; WEIGHT LOSS;

EID: 84908144797     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.03.025     Document Type: Article

References (50)

1. World Health Organization. Obesity. World Health Organization; 2013. Available at: . Accessed June 23, 2014. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/.
2. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
3. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
4. Bajzer M., Seeley R.J. Physiology: obesity and gut flora. Nature 2006, 444:1009-1010.
5. DiBaise J.K., Zhang H., Crowell M.D., Krajmalnik-Brown R., Decker G.A., Rittmann B.E. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008, 83:460-469.
6. Wan Y.M., Zhu Y.Q., Xia B., Luo J. Treating TNBS-induced colitis in rats with probiotics. Turk J Gastroenterol 2011, 22:486-493.
7. Food and Agriculture Organization of the United Nations and World Health Organization. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report; 2001. Available at: . Accessed June 23, 2014. http://www.fao.org/es/ESN/probio/probio.htm.
8. Mekkes M.C., Weenen T.C., Brummer R.J., Claassen E. The development of probiotic treatment in obesity: a review. Benef Microbes 2013, 1-10.
9. Aronsson L., Huang Y., Parini P., Korach-Andre M., Hakansson J., Gustafsson J.A., et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010, 5.
10. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individualswith type 2 diabetes mellitus. J Dairy Sci 2011, 94:3288-3294.
11. Moya-Perez A., Romo-Vaquero M., Tomas-Barberan F., Sanz Y., Garcia-Conesa M.T. Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity. Nutr Metab Cardiovasc Dis 2014, 24:57-64.
12. Yoo S.R., Kim Y.J., Park D.Y., Jung U.J., Jeon S.M., Ahn Y.T., et al. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013, 21:2571-2578.
13. Miyoshi M., Ogawa A., Higurashi S., Kadooka Y. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 2014, 53:599-606.
14. Zarrati M., Shidfar F., Nourijelyani K., Mofid V., Hossein Zadeh-Attar M.J., Bidad K., et al. Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001 modulate gene expression of subset specific transcription factors and cytokines in peripheral blood mononuclear cells of obese and overweight people. Biofactors 2013, 39:633-643.
15. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005, 24:481-491.
16. Larsen C.N., Nielsen S., Kaestel P., Brockmann E., Bennedsen M., Christensen H.R., et al. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur J Clin Nutr 2006, 60:1284-1293.
17. Vlieger A.M., Robroch A., van Buuren S., Kiers J., Rijkers G., Benninga M.A., et al. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula. A randomised controlled trial. Br J Nutr 2009, 102:869-875.
18. Rizzardini G., Eskesen D., Calder P.C., Capetti A., Jespersen L., Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr 2012, 107:876-884.
19. Gaon D., Garcia H., Winter L., Rodriguez N., Quintas R., Gonzalez S.N., et al. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 2003, 63:293-298.
20. Galdeano C.M., Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 2004, 97:673-681.
21. Perdigon G., Maldonado Galdeano C., Valdez J.C., Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002, 56(Suppl 4):S21-S26.
22. Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006, 13:219-226.
23. Galdeano C.M., de Moreno de LeBlanc A., Vinderola G., Bonet M.E., Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 2007, 14:485-492.
24. Maldonado Galdeano C., Novotny Nunez I., de Moreno de LeBlanc A., Carmuega E., Weill R., Perdigon G. Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice. BMC Gastroenterol 2011, 11:64.
25. Sainte-Marie A paraffin embedding technique for studies employing immunofluorescence. J Histochem Cytochem 1962, 10:150-156.
26. de Moreno de LeBlanc A., Dogi C.A., Galdeano C.M., Carmuega E., Weill R., Perdigon G. Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunol 2008, 9:27.
27. Craigie A.M., Lake A.A., Kelly S.A., Adamson A.J., Mathers J.C. Tracking of obesity-related behaviours from childhood to adulthood: a systematic review. Maturitas 2011, 70:266-284.
28. Aggarwal J., Swami G., Kumar M. Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res 2013, 7:173-177.
29. Poutahidis T., Kleinewietfeld M., Smillie C., Levkovich T., Perrotta A., Bhela S., et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One 2013, 8:e68596.
30. Kang J.H., Yun S.I., Park H.O. Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol 2010, 48:712-714.
31. Karlsson C.L., Molin G., Fak F., Johansson Hagslatt M.L., Jakesevic M., Hakansson A., et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br J Nutr 2011, 106:887-895.
32. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008, 32:1720-1724.
33. Cano P.G., Santacruz A., Trejo F.M., Sanz Y. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity (Silver Spring) 2013, 21:2310-2321.
34. Shen J., Obin M.S., Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013, 34:39-58.
35. Sikaris K.A. The clinical biochemistry of obesity. Clin Biochem Rev 2004, 25:165-181.
36. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G.G., Neyrinck A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60:2775-2786.
37. Hu X., Wang T., Li W., Jin F., Wang L. Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet. Lipids Health Dis 2013, 12:67.
38. Sommer F., Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013, 11:227-238.
39. Joyce S.A., Gahan C.G. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol 2014, 30:120-127.
40. Wolf K.J., Lorenz R.G. Gut microbiota and obesity. Curr Obes Rep 2011, 1:1-8.
41. Hullar M.A., Lampe J.W. The gut microbiome and obesity. Nestle Nutr Inst Workshop Ser 2012, 73:67-79.
42. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selectiveincreases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
43. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
44. Rao A.V., Bested A.C., Beaulne T.M., Katzman M.A., Iorio C., Berardi J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probioticin emotional symptoms of chronic fatigue syndrome. Gut Pathol 2009, 1:6.
45. Morales P., Brignardello J., Gotteland M. The association of intestinal microbiota with obesity. Rev Med Chil 2010, 138:1020-1027.
46. Solga S.F., Buckley G., Clark J.M., Horska A., Diehl A.M. The effect of a probiotic on hepatic steatosis. J Clin Gastroenterol 2008, 42:1117-1119.
47. Ma X., Hua J., Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008, 49:821-830.
48. Brandtzaeg P. Update on mucosal immunoglobulin A in gastrointestinal disease. Curr Opin Gastroenterol 2010, 26:554-563.
49. Sheikh S.Z., Plevy S.E. The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol 2010, 26:578-582.
50. Lawrence C.B., Brough D., Knight E.M. Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharide. Dis Model Mech 2012, 5:649-659.